Skip to content
Fiscal Receipts

Senate LDA lobbying filing

PFIZER

Registrant: FEDERAL HEALTH POLICY STRATEGIES Year: 2024 Period: Second Quarter Type: Q2

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities1

  • Health IssuesHCR

    Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency ActH.R. 8816, the American Medical Innovation and Investment Act

Lobbyists1

  • DAN ELLING

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.